Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/272.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Parasitic organism or component thereof or substance produced by said parasitic organism (e.g., schistosoma, dirofilaria, trichinella, fasciola, ancylostoma, ascaris, etc.) > Parasitic protozoan (e.g., trypanosoma, trichomonas, leishmania, entamoeba, etc.) > Plasmodium
Description: Subject matter wherein the parasitic protozoan is of the genus Plasmodium.

Patents under this class:
1 2 3

Patent Number Title Of Patent Date Issued
8709445 Vaccination with killed but metabolically active (KBMA) protozoans with toll-like receptor agonists Apr. 29, 2014
8703147 Methods and compositions for treating and preventing malaria (2) Apr. 22, 2014
8673311 Bacterial spore having therapeutic agent adsorbed on its surface Mar. 18, 2014
8501926 Malaria vaccine Aug. 6, 2013
8470560 CR-2 binding peptide P28 as molecular adjuvant for DNA vaccines Jun. 25, 2013
8465746 Compositions and methods for treatment, research and therapeutic applications for malaria Jun. 18, 2013
8450055 Malaria antigen screening method May. 28, 2013
8444989 One dose vaccination against mycoplasma infections of pigs May. 21, 2013
8444996 Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia May. 21, 2013
8383133 Conjugates of Plasmodium falciparum surface proteins as malaria vaccines Feb. 26, 2013
8367810 Purified plasmodium and vaccine compositions Feb. 5, 2013
8318185 Recombinant malaria vaccine Nov. 27, 2012
8309101 Pasteurella multocida vaccine Nov. 13, 2012
8268981 Plasmodium malariae and plasmodium ovale genes and uses thereof Sep. 18, 2012
8216593 Parasite vaccine Jul. 10, 2012
8206725 Immunogenic agent and pharmaceutical composition for use against homologous and heterologous pathogens including plasmodium SPP Jun. 26, 2012
8153140 Chimeric MSP-based malaria vaccine Apr. 10, 2012
8058249 Immunostimulatory nucleic acid molecules Nov. 15, 2011
8043625 Purified plasmodium and vaccine compositions Oct. 25, 2011
8021667 Compositions for immunotherapy and uses thereof Sep. 20, 2011
8017745 Plasmodium falciparum antigens and methods of use Sep. 13, 2011
8012493 Malaria vaccines Sep. 6, 2011
7931908 Chimeric MSP-based malaria vaccine Apr. 26, 2011
7887819 Antigenic polypeptide SE36 of malaria plasmodium, process for purification thereof, and vaccine and diagnostic agent using the antigen Feb. 15, 2011
7655247 Malaria vaccines Feb. 2, 2010
7595191 Isolation and purification of P. falciparum merozoite protein-142 vaccine Sep. 29, 2009
7575755 Immunogenic compositions and uses thereof Aug. 18, 2009
7563883 Recombinant P. falciparum merozoite protein-1.sub.42 vaccine Jul. 21, 2009
7541039 Immunization with bacterial ghost-based vaccines Jun. 2, 2009
7498037 Plasmodium falciparum antigens and their vaccine and diagnostic applications Mar. 3, 2009
7488489 Identification of a conserved region of Plasmodium falciparum MSP3 targeted by biologically active antibodies Feb. 10, 2009
7476386 Mixed lipopeptide micelles for inducing an immune response Jan. 13, 2009
7462358 Antigenic polypeptide SE36 of malaria plasmodium, process for purification thereof, and vaccine and diagnostic agent using the antigen Dec. 9, 2008
7438916 Therapeutic target for protozoal diseases Oct. 21, 2008
7438917 Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes Oct. 21, 2008
7431936 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and Oct. 7, 2008
7407658 Vaccines for blocking transmission of plasmodium vivax Aug. 5, 2008
7404962 Combination kit used in the treatment of malaria Jul. 29, 2008
7306806 Recombinant P. falciparum merozoite protein-142 vaccine Dec. 11, 2007
7285289 Nanoparticle vaccines Oct. 23, 2007
7273605 Vaccine Sep. 25, 2007
7256281 Recombinant P. falciparum merozoite protein-1.sub.42 vaccine Aug. 14, 2007
7229627 Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production Jun. 12, 2007
7198791 Compositions and methods for the generation of protective immune responses against malaria Apr. 3, 2007
7179615 Method of prophylaxis and treatment Feb. 20, 2007
7150875 Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine Dec. 19, 2006
7125958 Malaria polypeptides Oct. 24, 2006
7101556 Preparation and usage of plasmodium fusion antigen Sep. 5, 2006
7087231 Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes Aug. 8, 2006
7078043 Malaria vaccine Jul. 18, 2006

1 2 3

  Recently Added Patents
Method, apparatus, and system for energy efficiency and energy conservation including dynamic cache sizing and cache operating voltage management for optimal power performance
Thin film transistor and flat panel display device including the same
Memory system with data line switching scheme
Ultra-wideband communication system and method
1,3-diiodohydantoin compound and production method thereof
Vehicle display system or projection display for a motor vehicle, and calibration method
Method and system for modularized configurable connector system for ethernet applications
  Randomly Featured Patents
Voltage level shifter circuit
System and method of transliterating names between different languages
Damper device
Two mode electro-mechanical transmission and control
Instance-reduction algorithm for garbage-collected language
Method of enhancing oleophilic and hydrophobic properties of absorbent material
Imidazole ketone derivatives
Multi-track recording/reproducing apparatus, recording/reproducing method, and information recording medium
Fiber optic communication system with automatic line shutdown/power reduction
Neural network with multiplexed snyaptic processing